Sierra Oncology, Inc.

NasdaqGM:SRRA Stock Report

Market Cap: US$1.3b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Sierra Oncology Management

Management criteria checks 4/4

Key information

Stephen Dilly

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage29.6%
CEO tenure2.1yrs
CEO ownershipn/a
Management average tenure2yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Stephen Dilly's remuneration changed compared to Sierra Oncology's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2022n/an/a

-US$103m

Dec 31 2021US$2mUS$627k

-US$95m

Sep 30 2021n/an/a

-US$87m

Jun 30 2021n/an/a

-US$73m

Mar 31 2021n/an/a

-US$69m

Dec 31 2020US$8mUS$350k

-US$81m

Compensation vs Market: Stephen's total compensation ($USD2.12M) is below average for companies of similar size in the US market ($USD5.53M).

Compensation vs Earnings: Stephen's compensation has been consistent with company performance over the past year.

CEO

Stephen Dilly (62 yo)

2.1yrs

Tenure

US$2,115,229

Compensation

Dr. Stephen George Dilly, M.B.B.S, Ph D., serves as Director at ImmunoMolecular Therapeutics, Inc since February 2020. Dr. Dilly served as Director at DNAtrix, Inc. since 2019 until 2022 and served as its...

Leadership Team

NamePositionTenureCompensationOwnership
Stephen Dilly
President2.1yrsUS$2.12mno data
Sukhi Jagpal
Chief Financial Officer7.4yrsUS$1.00m0%
$ 0
Barbara Klencke
Chief Medical Officer7.1yrsUS$1.13m0%
$ 0
Christina Thomson
General Counsel2yrsno datano data
William Turner
Chief Regulatory & Technical Operations Officer1.9yrsno datano data
Kevin Norrett
Chief Business Officer1.9yrsno datano data

2.0yrs

Average Tenure

53.5yo

Average Age

Experienced Management: SRRA's management team is considered experienced (2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Stephen Dilly
President2.1yrsUS$2.12mno data
Robert Pelzer
Independent Chairman7.2yrsUS$164.69k0.020%
$ 275.0k
Bruce Zetter
Member of Scientific & Medical Advisory Boardno datano datano data
Jeffrey Cooper
Independent Director6.3yrsUS$132.93k0%
$ 0
Anthony Tolcher
Member of Scientific Advisory Boardno datano datano data
Andrew Sinclair
Independent Director2.7yrsUS$73.43k0%
$ 0
Ayad Al-Katib
Member of Scientific Advisory Board15.8yrsno datano data
Alan D'Andrea
Member of DDR Advisory Committee4.9yrsno datano data
Tim Moore
Member of Scientific & Medical Advisory Boardno datano datano data
Eric Brown
Member of DDR Advisory Committee4.9yrsno datano data
Karlene Cimprich
Member of DDR Advisory Committee4.9yrsno datano data
Alan Eastman
Member of DDR Advisory Committee4.9yrsno datano data

4.9yrs

Average Tenure

64yo

Average Age

Experienced Board: SRRA's board of directors are considered experienced (4.9 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.